Brain and Spine Metastasis

Brain and Spine Metastasis

58 items identified
A Study of SEA-CD40 Given with Other Drugs in Cancers (Melanoma)
A window of opportunity study of Patritumab Deruxtecan in patients with brain metastases
ABBV-400 for Advanced Solid Tumors
Alliance A071701 (Brain Metastases)
Alliance-A031704/PDIGREE (Renal Cell Cancer)
AMG 509 in patients with mCRPC (Prostate Cancer)
AMG 510 for colorectal or non-small-cell lung cancer with KRAS p.G12C mutation
AMG 510 in Advanced Solid Tumors With KRAS p.G12C Mutation
Amgen AMG 757 (Small Cell Lung Cancer)
ARC-21 (Gastrointestinal Cancer)
AVB-S6-500 in patients with advanced or metastatic clear cell renal cell carcinoma
Bellicum BPX-601 (Prostate Cancer)
BMX-MBM-001 (Brain Metastases)
Celldex CDX527-01 (Solid tumors)
CGX1321-101 (Gastrointestinal Cancer)
Circulating Biomarkers for Immunotherapy Resistance in Liver Cancer
COLOMATE: Colorectal Cancer Liquid Biopsy Screening for Molecularly Assigned Therapy
COMPOSE Study (Neuroendocrine Tumors)
Concurrent VRP-HER2 Vaccine + Pembrolizumab for HER2+ Breast Cancer
D3-002: A Study to Evaluate ETC-1922159 in Advanced Solid Tumors
DKN-01 in Combination with Tislelizumab ± Chemotherapy in Patients with Gastric Cancer
Domvanalimab and zimberelimab versus nivolumab in gastroesophageal cancer (STAR-221)
ECOG-ACRIN EAY131 (Solid Tumors, Lymphoma, or Multiple Myeloma)
Etigilimab with Nivolumab in Locally Advanced or Metastatic Solid Tumors
EV-103 enfortumab vedotin alone or with other therapies for urothelial cancer
FEATURES OF PRIMARY AND ADAPTIVE IMMUNOTHERAPY RESISTANCE IN MICROSATELLITE INSTABLE CANCERS
HCRN Lun19-427 (Small Cell Lung Cancer)
IDEAYA: (Melanoma with GNAQ/11 Mutations or PRKC Fusions)
Magnetic Resonance Imaging (MRI) for Assessing Spinal Metastases
Merck LiteSpark-011: Advanced rCC progression after immunotherapy (Renal Cell Carcinoma)
Merck U03B: Targeted combination therapies for second line ccRCC patients (Renal Cell Cancer)
Merck-U02-Substudy 02A_PD-1 Refractory Melanoma
Merck-U02-Substudy 02D (Melanoma with Brain Metastasis)
MOUNTAINEER-03 (Colorectal Cancer)
MRI following Stereotactic Radiosurgery for Brain Metastases
NUC-3373 for colorectal cancer
Panitumumab Rechallenge versus Standard Therapy for RAS Wild-Type Colorectal Cancer
Pembrolizumab plus lenvatinib and belzutifan for specified solid tumors
Pfizer - C4201002 (Solid Tumors)
Pfizer C4471001 (BRAF V600): Solid Tumors
Propella: Intramuscular abiraterone decanoate for metastatic prostate cancer
PSMAfore: Lu-PSMA for men with castrate-resistant prostate cancer
PT-112 in mCRPC (Prostate Cancer)
Relatlimab-nivolumab versus regorafenib or trifluridine + tipiracil for colorectal cancer
SGNTUC-024 (HER2+ Gastrointestinal Cancers)
SRS and Olaparaib followed by Durvalumab in Breast Cancer with Brain Metastases
Stellar-002: XL-092 (Kidney, Bladder, and Prostate Cancer)
STICk-IM NSCLC (Non-Small Cell Lung Cancer with Brain Metastases)
Synthekine STK-012 (Solid Tumors)
TBCRC045-AVIATOR for HER2+ Metastatic Breast Cancer